Day 3 Program FDA Session: HR+ Metastatic Breast Cancer in 2025—Progress, Regulatory Approvals, and the Trials Ahead Day 3: December 11, 2025 4:30 PM–6:00 PM CST Add to Calendar Google Calendar iCalendar (.ics) Session Details
